The Infected TKA – What Are My Options

1. High-Yield Summary

• Clinical Burden and Incidence: Periprosthetic joint infection (PJI) occurs in 1% to 2% of primary total knee arthroplasties (TKA) and up to 5% to 10% of revision reconstructions. It represents the primary mode of mechanical and biological failure within the first two postoperative years, exacting profound physical, financial, and psychological morbidity.
• Standardized Diagnostic Thresholds: Diagnostic confirmation adheres to the 2018 International Consensus Meeting (ICM) criteria. Major criteria—a sinus tract communicating directly with the prosthesis or two positive periprosthetic cultures yielding phenotypically identical organisms—are definitive for infection. Minor criteria aggregate weighted scores from serum biomarkers (C-reactive protein > 10 mg/L, D-dimer, erythrocyte sedimentation rate > 30 mm/hr) and synovial aspirate parameters (leukocyte count > 3,000 cells/uL, polymorphonuclear percentage > 70%, positive leukocyte esterase, and elevated alpha-defensin).
• Chronological Classification and the Biofilm Window: Surgical decision-making is strictly governed by symptom duration and implant stability. Acute postoperative infection (occurring within 3 to 4 weeks of index arthroplasty) and acute hematogenous seeding (with symptoms under 3 weeks in a previously well-functioning joint) exhibit immature bacterial biofilms, preserving a window for implant retention. Chronic infections (>4 weeks from surgery or indolent presentation) harbor mature, exopolysaccharide-encased biofilms requiring complete hardware and cement extraction.
• Surgical Treatment Spectrum: Therapeutic pathways include: (1) Debridement, Antibiotics, and Implant Retention (DAIR) with mandatory modular polyethylene insert exchange; (2) Single-stage direct exchange arthroplasty for strictly selected patients with identified, highly sensitive pathogens and uncompromised soft tissues; (3) Two-stage exchange arthroplasty utilizing an articulating or static antibiotic-loaded polymethylmethacrylate (PMMA) spacer, which remains the benchmark eradication modality; and (4) Salvage pathways, including lifelong suppressive oral antibiotic therapy, knee arthrodesis, and above-knee amputation (AKA).
• Extensor Mechanism and Bone Stock Preservation: Successful eradication without catastrophic disability mandates meticulous preservation of the extensor apparatus (quadriceps tendon, patella, patellar tendon, tibial tubercle) and reconstruction of metaphyseal osseous defects (Anderson Orthopaedic Research Institute [AORI] Types I-III) using modular sleeves, porous tantalum cones, and extended intramedullary stems.

2. Surgical Anatomy and Pathoanatomy

Management of the infected total knee demands comprehensive understanding of the periarticular soft-tissue envelope, neurovascular safe corridors, and patterns of osseous destruction secondary to inflammatory osteolysis and surgical debridement.

The Soft-Tissue Envelope and Extensor Apparatus

The anterior soft-tissue envelope of the knee is vulnerable to hypovascularity and wound dehiscence, particularly following multiple prior surgical incisions. The medial parapatellar approach provides universal exposure, utilizing the vascularized tissue plane between the vastus medialis and rectus femoris. The superior and inferior medial genicular arteries provide critical collateral perfusion to the anterior skin flap. Dissection must avoid undermining subcutaneous flaps thinner than 5 mm to prevent ischemic necrosis. The extensor mechanism is the critical determinant of ambulatory function; excessive traction on the patellar tendon during eversion can precipitate patellar tendon avulsion from the tibial tubercle, a catastrophic complication. When severe arthrofibrosis or scarring restricts exposure, extensile maneuvers such as a quadriceps “rectus snip”, V-Y quadriceps turndown, or tibial tubercle osteotomy (TTO) must be selected proactively rather than risking extensor rupture.

Neurovascular Danger Zones

Surgical debridement and implant extraction place several major neurovascular structures at immediate risk:

• Popliteal Neurovascular Bundle: Located immediately posterior to the posterior cruciate ligament (PCL) footprint and posterior joint capsule. In revision knee arthroplasty and severe PJI, inflammatory thickening and capsular contracture tether the popliteal artery directly against the posterior aspect of the proximal tibial cortex. Extensile posterior capsular debridement or blind osteotome placement for tibial tray extraction hazards vascular laceration or pseudoaneurysm formation. The knee should be held in 90 degrees of flexion during posterior debridement to displace the popliteal artery posteriorly.
• Common Peroneal Nerve (CPN): Courses around the posterior margin of the biceps femoris tendon and wraps closely around the lateral aspect of the fibular neck. The nerve is vulnerable to direct laceration during posterolateral capsular release, thermal injury from exothermic PMMA spacers, and stretch neuropraxia following correction of fixed valgus or severe flexion contractures.
• Infrapatellar Branch of the Saphenous Nerve: Traverses anterior to the medial joint line. Transection leads to postoperative anterior knee numbness and occasional painful neuroma formation, which must be distinguished from recurrent joint pain.

Metaphyseal and Diaphyseal Bone Deficiencies

Bacterial proliferation, osteoclast activation, and mechanical component extraction cause significant bone loss categorized by the Anderson Orthopaedic Research Institute (AORI) classification:

• AORI Type 1 (Minor Metaphyseal Defect): Intact metaphyseal cancellous bone with stable cortical margins. Cancellous bone loss can be managed with morselized bone graft or standard cement.
• AORI Type 2 (Damaged Metaphysis): Loss of cancellous bone in one or both femoral condyles or tibial hemi-plateaus. Mandates augmentation with metal blocks, wedges, modular porous metal sleeves, or tantalum cones to restore the joint line.
• AORI Type 3 (Deficient Metaphysis): Complete compromise of the metaphyseal segment with cortical destruction extending toward the diaphysis. Requires long intramedullary stems, massive structural porous cones, or distal femoral/proximal tibial replacement (megaprosthesis).

3. Pathogenesis and Microbiology

Periprosthetic joint infection is initiated when bacteria inoculate the surgical field via intraoperative airborne contamination, direct seeding from the skin envelope, contiguous spread from adjacent soft tissue, or hematogenous dissemination from distant anatomical sites (e.g., dentoalveolar, urinary tract, gastrointestinal, or vascular catheter infections).

Biofilm Kinetics and Microbial Tolerance

Within hours of implant insertion, host proteins (fibronectin, fibrinogen, vitronectin) coat the prosthetic cobalt-chromium, titanium, and ultra-high-molecular-weight polyethylene surfaces. Planktonic microorganisms adhere through nonspecific electrostatic forces followed by specific adhesin-mediated attachment. Proliferating bacteria secrete an extracellular polymeric substance (EPS) matrix consisting of polysaccharides, extracellular DNA, and structural proteins, forming a mature biofilm.

Within the mature biofilm architecture, bacterial colonies enter a dormant, metabolically quiescent “persister” state. Biofilm-embedded organisms demonstrate profound phenotypic resistance to host immune surveillance (phagocytosis and antibody neutralization) and up to 1,000-fold higher minimum inhibitory concentrations (MIC) for conventional antimicrobial agents. Mature biofilms become irreversible between 3 and 4 weeks following colonization, establishing the strict biological window after which implant salvage via DAIR consistently fails.

Microbiological Spectrum

The microbial etiology of TKA periprosthetic joint infection encompasses distinct pathogen classes:

• Gram-Positive Cocci (65% to 75%): Staphylococcus aureus (including methicillin-sensitive [MSSA] and methicillin-resistant [MRSA] strains) and coagulase-negative Staphylococci (predominantly Staphylococcus epidermidis and virulent Staphylococcus lugdunensis) represent the most frequent causative agents. Streptococcal species (e.g., Streptococcus viridans, Streptococcus agalactiae) and Enterococcus faecalis account for 10% to 15%.
• Gram-Negative Bacilli (10% to 15%): Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Gram-negative infections correlate with heightened recurrence risks and inferior functional survivorship.
• Polymicrobial Infections (10% to 15%): Frequently observed in the setting of chronic draining sinuses, cutaneous ulceration, or multiple prior surgical revisions. Eradication rates are significantly lower compared to monomicrobial PJI.
• Atypical and Fungal Organisms (1% to 3%): Candida albicans, Candida parapsilosis, and atypical mycobacteria. Associated with profound immunosuppression and prolonged prior antibiotic therapy.
• Culture-Negative PJI (5% to 12%): Represents true infection where standard aerobic and anaerobic broth cultures yield no growth, frequently due to empirical antibiotic administration prior to joint aspiration, fastidious organisms (e.g., Cutibacterium acnes), or small-colony variants.

4. Natural History and Risk Stratification

If untreated or inadequately managed, periprosthetic knee infection progresses from indolent joint pain and effusion to osteolytic hardware loosening, persistent sinus tract drainage, extensor mechanism necrosis, catastrophic sepsis, and limb loss. Population-based registries document that the 5-year mortality rate following surgical treatment for PJI approaches 20% to 25%, surpassing the mortality of कई common solid organ malignancies.

Host Optimization and Stratification

Host immune competence and systemic comorbidity directly dictate the probability of infection eradication. The McPherson Staging System stratifies patients into three host categories:

• Class A (Uncompromised Host): Normal systemic defense mechanisms without significant chronic morbidities. Excellent physiologic healing reserve.
• Class B (Compromised Host): One or more systemic compromise factors, including poorly controlled diabetes mellitus (HbA1c > 7.5% – 8.0%), morbid obesity (BMI > 40 kg/m²), active nicotine use, chronic kidney disease (eGFR < 30 mL/min), inflammatory arthropathy on disease-modifying agents, chronic hepatic insufficiency, and malnutrition (serum albumin < 3.5 g/dL, total lymphocyte count < 1,500 cells/uL).
• Class C (Prohibitive Host): Severe systemic compromise where surgical intervention carries an unacceptable mortality risk. Candidates for nonoperative suppression or limb salvage.

5. Clinical Presentation and Diagnostic Examination

History and Symptom Onset

Clinical evaluation requires differentiating acute surgical emergencies from indolent prosthetic failure. Acute infections present with rapid-onset severe arthralgia, joint fullness, local warmth, periarticular erythema, and wound discharge within 30 days of surgery or following an identifiable bacteremic event. Conversely, chronic PJI manifests as progressive, unremitting mechanical pain, gradual loss of knee range of motion, recurrent joint effusions, or persistent unexplained dissatisfaction following an initial asymptomatic recovery period.

Physical Examination Maneuvers

A systematic physical exam must be performed in every suspected case:

• Cutaneous Inspection and Sinus Tract Probing: Thorough inspection for erythema, surgical scar necrosis, and cutaneous sinus tracts. A draining sinus communicating with the joint capsule or visible prosthetic hardware is pathognomonic for PJI.
• Patellar Ballottement and Effusion Quantification: Palpation of the suprapatellar pouch. A tense, warm, hyperemic joint effusion indicates severe intra-articular inflammation.
• Extensor Mechanism Integrity Testing: Active straight leg raise against gravity to evaluate for extensor lag, quadriceps tendon disruption, or patellar tendon attenuation.
• Ligamentous and Hardware Stability Assessment: Coronal stress testing (varus and valgus at 0 and 30 degrees of flexion) and sagittal translation to detect gross ligamentous incompetence or catastrophic component subsidence.
• Distal Neurovascular Examination: Palpation of dorsalis pedis and posterior tibial pulses, capillary refill time, and motor/sensory testing of the deep and superficial peroneal nerves and tibial nerve.

6. Diagnostic Workup and Biomarker Stratification

Accurate diagnosis mandates a standardized diagnostic algorithm combining serologic markers, synovial fluid analysis, radiographic evaluation, and microbiological confirmation.

Serologic Screening Hierarchy

Serum biomarkers constitute the first-line screening tier:

• C-Reactive Protein (CRP): Rapid hepatic acute-phase reactant. Peaks on postoperative day 2 to 3 and normalizes within 4 to 6 weeks. Serum CRP > 10 mg/L in chronic settings (>100 mg/L in acute postoperative settings) demonstrates high sensitivity (88% to 92%) for periprosthetic infection.
• Erythrocyte Sedimentation Rate (ESR): Indirect measure of serum fibrinogen. Normalizes gradually over 3 to 6 months postoperatively. Chronic threshold of ESR > 30 mm/hr provides supplementary specificity when paired with CRP.
• Serum D-Dimer: Elevated in the presence of active intra-articular fibrinolysis. A threshold of >850 ng/mL demonstrates high diagnostic sensitivity, though concurrent systemic inflammatory conditions or venous thromboembolism confound interpretation.

Synovial Fluid Arthrocentesis (Gold Standard)

Knee aspiration must be performed under strict aseptic technique before the initiation of empirical antibiotic therapy. If antibiotics have been administered, they should ideally be withheld for at least 14 days prior to aspiration if clinically safe:

• Synovial White Blood Cell (WBC) Count and Differential: In chronic PJI, synovial WBC count > 3,000 cells/uL with >70% polymorphonuclear cells (PMN) is diagnostic. In the acute postoperative period ( 10,000 cells/uL with >90% PMN).
• Synovial Leukocyte Esterase (LE): Rapid colorimetric strip assay. A reading of ++ (two-plus) correlates strongly with infection (>90% specificity). Bloody aspirates must be centrifuged before interpretation to prevent false-positive results.
• Alpha-Defensin Immunoassay: Antimicrobial peptide released by neutrophils in response to intra-articular pathogens. Demonstrates sensitivity and specificity exceeding 95%, maintaining diagnostic accuracy even in patients on concurrent antibiotic suppression.
• Synovial Cultures: Inoculated directly into blood culture bottles (aerobic and anaerobic) and standard agar media. Cultures should be incubated for at least 14 days to capture slow-growing, fastidious organisms such as Cutibacterium acnes.

Radiographic and Advanced Imaging

Weight-bearing anteroposterior (AP), lateral, and merchant patellar views are evaluated for: (1) progressive radiolucent lines > 2 mm at the bone-cement or bone-implant interface; (2) focal osteolysis in non-wear zones; (3) acute component subsidence or migration; and (4) periosteal bone formation. Computed tomography (CT) with metal artifact reduction software (MARS) provides three-dimensional delineation of structural bone loss and rotational component alignment.

7. Classification and Diagnostic Criteria

Standardized diagnostic and staging classification systems guide clinical decision-making and dictate whether implant salvage is biologically feasible.

The 2018 International Consensus Meeting (ICM) Diagnostic System

The validated 2018 ICM criteria employ a point-scoring framework differentiating definitive infection from indeterminate states:

Diagnostic Tier	Clinical or Laboratory Finding	Point Weight	Clinical Interpretation
Major Criteria	Sinus tract communicating with prosthesis OR Two positive periprosthetic cultures with phenotypically identical organisms	Definitive	Infection is conclusively established; no further scoring required.
Minor Criteria (Preoperative)	Elevated Serum CRP (>10 mg/L) or D-dimer (>860 ng/mL)	2 Points	Scoring Thresholds: • ≥6 Points: Infected • 2-5 Points: Inconclusive • 0-1 Point: Not Infected
Minor Criteria (Preoperative)	Elevated Serum ESR (>30 mm/hr)	1 Point	Supplementary systemic inflammatory marker.
Minor Criteria (Preoperative)	Elevated Synovial WBC (>3,000 cells/uL) or positive Leukocyte Esterase (++)	3 Points	Indicates dense neutrophil infiltration.
Minor Criteria (Preoperative)	Positive Synovial Alpha-Defensin (immunoassay or lateral flow)	3 Points	High-specificity intra-articular antimicrobial peptide.
Minor Criteria (Preoperative)	Elevated Synovial Polymorphonuclear Percentage (>70% PMN)	2 Points	Reflects active acute phagocytic response.
Minor Criteria (Intraoperative)	Positive Histology (≥5 neutrophils per high-power field in 5 HPFs at ×400)	3 Points	Frozen section biopsy confirmation.
Minor Criteria (Intraoperative)	Positive Intraoperative Purulence	3 Points	Gross intra-articular frank pus.
Minor Criteria (Intraoperative)	Single Positive Intraoperative Periprosthetic Culture	2 Points	Supports secondary microbiological criteria.

Tsukayama Clinical Classification of PJI

The Tsukayama staging system categorizes periprosthetic infection based on clinical timing and mechanism of presentation:

Type	Clinical Category	Diagnostic Criteria	Primary Surgical Strategy
Type I	Positive Intraoperative Cultures	Two or more positive cultures harvested during revision surgery for presumed aseptic loosening.	Implant retention with tailored long-term antibiotic therapy (minimum 6 weeks targeted IV/oral).
Type II	Early Postoperative Infection	PJI developing ≤4 weeks following the index total knee arthroplasty procedure.	DAIR with mandatory modular insert exchange, synovectomy, and biofilm-active antimicrobials.
Type III	Acute Hematogenous Infection	Sudden onset of acute joint symptoms (<3 weeks duration) in a previously well-functioning, pain-free TKA.	DAIR with modular insert exchange if implants remain rigidly fixed and soft tissues are uncompromised.
Type IV	Late Chronic Infection	Indolent or progressive infection presenting >4 weeks postoperatively with symptoms >3-4 weeks.	Two-stage exchange arthroplasty (or one-stage exchange in strict selected candidates).

8. Treatment Options and Surgical Decision Algorithms

Therapeutic selection must be tailored to symptom duration, pathogen virulence, implant stability, soft-tissue integrity, and host physiological reserve.

Nonoperative and Chronic Suppressive Antimicrobial Therapy

Chronic suppressive antibiotic therapy is strictly reserved for patients who are medically unfit for major surgical intervention (McPherson Class C hosts), patients with prohibitive perioperative mortality risks, or individuals with well-fixed, functionally stable implants where surgical revision is declined. Prerequisites include: (1) known causative microorganism with available low-toxicity oral antimicrobial agent; (2) well-tolerated oral regimen; and (3) absence of systemic sepsis or progressive osteolysis. Lifetime suppression carries a failure rate of 40% to 60%, with risks of antimicrobial toxicity (hepatic, renal, bone marrow suppression), Clostridioides difficile colitis, and eventual emergence of drug-resistant strains.

Debridement, Antibiotics, and Implant Retention (DAIR)

DAIR aims to eradicate infection while salvaging the well-fixed primary components. Strict surgical indications include:

• Acute postoperative infection within 3 to 4 weeks of index arthroplasty, or acute hematogenous seeding with under 3 weeks of clinical symptoms.
• Rigidly fixed femoral and tibial components without radiolucent lines or mechanical loosening.
• Healthy soft-tissue envelope without extensive necrosis or sinus tracts.
• Identification of an antibiotic-susceptible organism with established biofilm-active regimens (e.g., MSSA with rifampin susceptibility).

Critical Operative Steps: The procedure mandates complete arthrotomy, radical synovectomy of the suprapatellar pouch and gutters, and mandatory removal and exchange of the modular polyethylene insert. Leaving the original insert prevents debridement of the posterior femoral and tibial condylar recesses and preserves a colonized biofilm reservoir. High-volume dilute antiseptic irrigation (e.g., dilute povidone-iodine or chlorhexidine gluconate) utilizing 6 to 9 liters of fluid is delivered before placing a new sterile trial and definitive polyethylene insert.

One-Stage Direct Exchange Arthroplasty

Single-stage revision involves radical debridement, complete removal of all foreign hardware and cement, followed immediately by re-prepping, re-draping, re-instrumentation, and implantation of a definitive revision prosthesis during the same surgical session.

• Selection Criteria: Preoperatively identified organism with known antibiotic sensitivity; absence of antibiotic-resistant or atypical pathogens (MRSA, Vancomycin-Resistant Enterococci [VRE], fungal species); uncompromised, well-vascularized soft-tissue envelope without a draining sinus; intact extensor mechanism; and adequate host healing capacity.
• Technical Discipline: Two separate surgical stages under one anesthetic. Stage 1 executes complete explantation and radical debridement. The surgical team then changes gowns and gloves, completely re-drapes the field, and uses dedicated revision instruments for Stage 2. High-dose organism-specific antibiotic-impregnated bone cement is utilized for component fixation.

Two-Stage Exchange Arthroplasty (Gold Standard)

Two-stage exchange remains the gold standard in North American practice, particularly for chronic infections, multi-drug resistant pathogens, polymicrobial PJI, or cases with severe soft-tissue compromise:

• Stage 1 (Resection and Spacer Placement): Complete hardware, plug, and cement removal. Radical debridement of all contaminated synovium, necrotic bone, and fibrous membranes. Placement of an antibiotic-loaded PMMA spacer. Spacers are classified as:
  • Articulating (Dynamic) Spacers: Cement-on-cement or metal-on-polyethylene articulating molds. Preserves knee range of motion, maintains quadriceps tension, prevents joint line scar contracture, and facilitates surgical exposure during Stage 2.
  • Static Spacers (Block): Utilized when severe ligamentous instability, massive bone loss (AORI Type 3), or extensor mechanism compromise precludes stable articulation. Requires rigid immobilization with a knee immobilizer or hinged brace.
  Cement antibiotic dosing: 3 to 4 g of heat-stable antibiotic powder (typically 2 to 3 g vancomycin plus 1.2 to 2.4 g tobramycin or gentamicin) per 40 g batch of PMMA cement. Total antibiotic mass should not exceed 8 g per 40 g cement to prevent structural crumble.
• Interim Antimicrobial Phase: 6 weeks of pathogen-directed intravenous or high-bioavailability oral antibiotic therapy, followed by an antibiotic holiday of 2 to 4 weeks. Serial serum CRP and ESR are monitored to confirm clinical resolution. Repeat knee aspiration before Stage 2 is performed if clinical suspicion persists.
• Stage 2 (Reimplantation): Re-exploration, spacer extraction, frozen section histopathological evaluation (confirming <5 PMNs/HPF across multiple fields), repeat microbiological sampling, and definitive revision total knee reconstruction utilizing metaphyseal sleeves, porous tantalum cones, and stemmed constrained condylar knee (CCK) or rotating hinge knee (RHK) prostheses.

Salvage Procedures: Knee Arthrodesis and Amputation

When joint reconstruction is unfeasible, salvage pathways preserve limb stability or eradicate life-threatening infection:

• Knee Arthrodesis: Indicated for: (1) irreparable disruption of the extensor mechanism; (2) massive metaphyseal and diaphyseal bone loss precluding implant stability; (3) highly recalcitrant infections after multiple failed exchange attempts; and (4) young manual laborers requiring a durable, stable limb. Techniques utilize a long modular intramedullary nail spanning from femur to tibia, or circular external fixation (Ilizarov/Taylor Spatial Frame). Fusion rates range from 80% to 90% with intramedullary nailing.
• Above-Knee Amputation (AKA): The ultimate salvage procedure. Indicated for: (1) life-threatening necrotizing soft-tissue infection or refractory systemic sepsis; (2) severe persistent neurovascular compromise; (3) extensive soft-tissue defects untreatable with free tissue transfer; and (4) intractable pain and total bedbound debility after exhausted surgical revisions. Prosthetic ambulation rates following transfemoral amputation for PJI are low (<20% to 30%), with significant 1-year mortality.

9. Clinical Outcomes and Eradication Rates

Comparative clinical outcomes demonstrate significant variability governed by surgical strategy, host stratification, and pathogen characteristics:

• DAIR Eradication Rates: In strictly selected early acute infections (4 weeks) yields dismal eradication rates (<30% to 35%), with subsequent revision demonstrating higher failure rates than primary two-stage exchange.
• One-Stage vs Two-Stage Exchange: In appropriately selected single-stage cohorts (susceptible Gram-positive organisms, intact soft tissues), infection-free survival reaches 85% to 90%, matching two-stage exchange cohorts while avoiding the morbidity and functional decline of a second operation. Two-stage exchange demonstrates 85% to 92% infection eradication in broad revision populations, though reinfection rates rise sharply in resistant organisms (MRSA, VRE) and McPherson Class C hosts.
• Functional Outcomes: Patient-reported outcome measures (Knee Society Score [KSS], Oxford Knee Score, WOMAC) following successful two-stage revision are consistently lower than primary TKA, with mean postoperative flexion averaging 90 to 105 degrees. Articulating spacers confer superior postoperative range of motion (mean gain 10 to 15 degrees) compared to static cement blocks.

10. Complications and Failure Modes

Surgical intervention for infected total knee arthroplasty carries substantial morbidity categorized by operative timeline:

Phase	Complication	Pathophysiologic Mechanism	Prevention and Mitigation Strategy
Intraoperative	Extensor Mechanism Disruption	Excessive traction or avulsion of patellar tendon during eversion in scarred knees.	Proactive extensile exposure: rectus snip, V-Y turndown, or tibial tubercle osteotomy.
Intraoperative	Popliteal Vascular Laceration	Direct injury from posterior osteotomes or retractors during tibial explantation.	Maintain knee in 90° flexion; visualize posterior cortex; avoid blind posterior plunging.
Intraoperative	Femoral/Tibial Cortical Perforation	Cortical breach during cement mantle clearance or flexible osteotome extraction.	Utilize guided extraction tools, ultrasound debriders, and intraoperative fluoroscopy.
Early Postoperative	Spacer Dislocation or Subluxation	Inadequate spacer sizing, asymmetric ligamentous laxity, or soft-tissue insufficiency.	Accurate joint line tensioning; select static spacer if collateral ligaments are deficient.
Early Postoperative	Acute Kidney Injury (AKI)	Nephrotoxicity from high-dose aminoglycoside/vancomycin spacer elution or systemic IV therapy.	Limit cement antibiotic mass to ≤8 g per 40 g batch; monitor serum trough levels and renal panel.
Early Postoperative	Wound Dehiscence / Flap Necrosis	Microvascular ischemia in thin anterior skin flaps or multiple competing incisions.	Utilize most lateral prior scar; avoid subcutaneous undermining; plastic surgery flap coverage.
Late Postoperative	Recurrent / Persistent PJI	Persistent microbial biofilm, persister cells, or new hematogenous seeding.	Complete hardware/cement removal; extended incubation; repeat two-stage or arthrodesis.
Late Postoperative	Aseptic Loosening / Structural Failure	Inadequate metaphyseal fixation, high constraint interface stresses, or severe bone loss.	Zonal fixation with modular porous cones/sleeves and extended diaphyseal stems.

11. Pearls and Pitfalls

• The Diagnostic Antimicrobial Discipline: Never initiate empirical antibiotics in a patient with a suspected infected knee before obtaining an authoritative synovial fluid aspirate. Indiscriminate antibiotic therapy drops synovial culture sensitivity by 50%, converting a diagnosable monomicrobial infection into a hazardous culture-negative scenario.
• The Polyethylene Exchange Imperative in DAIR: Retention of the original modular polyethylene insert during DAIR is a critical surgical error. Biofilm clings tenaciously to the underside of the insert and the locked locking mechanisms, and the posterior capsule cannot be accessed without insert removal. Modular insert exchange must be performed in every DAIR procedure.
• Spacer Joint Line and Extensor Maintenance: In two-stage exchange, never underestimate spacer thickness. Allowing the joint line to collapse with a thin, loose spacer results in quadriceps contracture, patella baja, and extensive scar formation, converting the second-stage reimplantation into a surgical nightmare. Maintain anatomic extensor tension with a well-sized articulating spacer.
• Cement Mantle Extraction Vigilance: Retained cement fragments after Stage 1 resection serve as a persistent nidus for bacterial colonization. Complete, meticulous extraction of all PMMA cement—including cement within distal anchoring holes and intramedullary plugs—is mandatory. Postoperative AP, lateral, and oblique radiographs should be inspected to confirm complete cement clearance before closure.

12. Controversy and Emerging Paradigms

The management of periprosthetic knee infection is undergoing a paradigm shift driven by high-level clinical trials and novel biological technologies:

A primary ongoing debate involves the routine adoption of one-stage exchange arthroplasty versus the historical two-stage standard. While European centers have long reported comparable eradication rates with single-stage protocols, North American practice has traditionally favored two-stage revision. Recent prospective randomized trial evidence demonstrates that for patients with identifiable, sensitive pathogens, uncompromised soft tissues, and good bone stock, one-stage exchange provides equivalent infection-free survivorship at two years with significantly less cumulative surgical morbidity, better functional recovery, and reduced overall healthcare expenditure.

A second major evolution surrounds the duration and route of systemic antimicrobial therapy. Following the landmark OVIVA (Oral Versus Intravenous Antibiotics for Bone and Joint Infection) trial, evidence indicates that early transition to targeted, highly bioavailable oral antibiotic therapy is non-inferior to prolonged 6-week intravenous catheter courses, avoiding complications associated with central venous access (line sepsis, thrombosis). Finally, the integration of bioabsorbable antibiotic-eluting calcium sulfate beads and synthetic hydrogels offers unprecedented local antibiotic concentrations far exceeding systemic thresholds without the need for secondary surgical removal.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

Clinical Question / Investigation	Level of Evidence	Pivotal Landmark Study	Study Design & Methodology	Cohort Size / Follow-up	Primary Outcome / Effect Size	DOI
Efficacy of DAIR in early acute TKA/THA periprosthetic joint infection	Level I (Therapeutic)	Longo UG, De Salvatore S, Bandini B et al (2024)	Systematic Review / Meta-Analysis	28 studies (1,296 patients)	Overall infection eradication rate of 68-72%; modular component exchange significantly improved success.	DOI
One-stage versus two-stage exchange arthroplasty for chronic PJI eradication	Level I (Therapeutic)	Fehring TK, Otero JE, Fehring KA et al (2026)	Randomized Controlled Trial	Prospective randomized trial cohort	Equivalent infection-free survivorship at 2-year follow-up with lower cumulative morbidity in one-stage exchange.	DOI
Chlorhexidine/povidone-iodine vs saline irrigation in total joint arthroplasty	Level I (Therapeutic)	Machinski E, da Cruz VF, Conde RAS et al (2025)	Systematic Review / Meta-Analysis	14 comparative studies	Dilute antiseptic surgical irrigation significantly reduced prosthetic joint infection relative to saline lavage.	DOI
Evidence-based diagnostic criteria and scoring algorithm for PJI	Level V (Expert Conceptual Review)	Javad Parvizi, Timothy L. Tan, Karan Goswami et al (2018)	Seminal Conceptual / Observational Study	Multi-institutional ICM validation cohort	Validated scoring criteria with major criteria and scored minor criteria achieving >95% sensitivity and specificity.	DOI
Clinical practice guidelines for antimicrobial therapy and surgical management in PJI	Level V (Expert Conceptual Review)	Douglas R. Osmon, Elie F. Berbari, Anthony R. Berendt et al (2012)	Seminal Conceptual / Observational Study	IDSA expert consensus guideline	Comprehensive surgical and antimicrobial pathways differentiating acute vs chronic infection and biofilm-directed therapy.	DOI

14. References

• Longo UG, De Salvatore S, Bandini B et al. Debridement, antibiotics, and implant retention (DAIR) for the early prosthetic joint infection of total knee and hip arthroplasties: a systematic review. J ISAKOS. 2024. doi:10.1016/j.jisako.2023.09.003 [Level I (Therapeutic): Systematic Review / Meta-Analysis]
• Fehring TK, Otero JE, Fehring KA et al. One-Stage Versus Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection: A Prospective Randomized Trial. J Bone Joint Surg Am. 2026. doi:10.2106/JBJS.25.00713 [Level I (Therapeutic): Randomized Controlled Trial]
• Machinski E, da Cruz VF, Conde RAS et al. Chlorhexidine or Povidone-Iodine Solution Irrigation Versus Saline Irrigation for the Prevention of Postoperative Infections in Primary Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2025. doi:10.1016/j.arth.2025.02.037 [Level I (Therapeutic): Systematic Review / Meta-Analysis]
• Javad Parvizi, Timothy L. Tan, Karan Goswami et al. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. The Journal of Arthroplasty. 2018. doi:10.1016/j.arth.2018.02.078 [Level V (Expert Conceptual Review): Seminal Conceptual / Observational Study]
• Douglas R. Osmon, Elie F. Berbari, Anthony R. Berendt et al. Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa. Clinical Infectious Diseases. 2012. doi:10.1093/cid/cis803 [Level V (Expert Conceptual Review): Seminal Conceptual / Observational Study]

15. Master Class Pro-Tip

The Complete Modular Debridement Rule and Spacer Joint Line Preservation: When undertaking DAIR for early acute periprosthetic knee infection, retention of the polyethylene insert is an absolute never-event. Leaving the original insert in place precludes access to the posterior capsule, the posterior condylar recesses, and the tibial baseplate interface where biofilm persists unabated. The insert must be removed, the posterior condyles thoroughly exposed through flexion and anterior tibial subluxation, and radical synovectomy performed with dilute antiseptic lavage before placing a new sterile insert. In two-stage exchange, never let the joint line collapse into hyperextension with an undersized spacer. Maintaining a balanced extensor tension with an articulating cement spacer prevents proximal migration of the patella and quadriceps scarring, transforming what would be an impossible second-stage exposure requiring an extensile rectus snip or tibial tubercle osteotomy into a straightforward revision arthroplasty.

Master Class Surgical Pearl: Strategic Debridement Discipline and Extensor Mechanism Preservation in TKA Infection